134 related articles for article (PubMed ID: 25974985)
1. Flow cytometric study of cell cycle and DNA ploidy in bilharzial bladder cancer.
El-Gamal EM; Gouida MS
Clin Lab; 2015; 61(3-4):211-8. PubMed ID: 25974985
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: a long-term follow-up study.
Tachibana M; Miyakawa A; Miyakawa M; Saito S; Nakamura K; Baba S; Murai M
Cancer Detect Prev; 1999; 23(2):155-62. PubMed ID: 10101597
[TBL] [Abstract][Full Text] [Related]
3. Origins and clinical implications of aneuploidy in early bladder cancer.
Shackney SE; Berg G; Simon SR; Cohen J; Amina S; Pommersheim W; Yakulis R; Wang S; Uhl M; Smith CA
Cytometry; 1995 Dec; 22(4):307-16. PubMed ID: 8749781
[TBL] [Abstract][Full Text] [Related]
4. [DNA ploidy and cell cycle phase analysis with flow cytometry in bladder wash. Preliminary experience].
Rivas del Fresno M; Salas Bustamante A; Suárez González JA; Tardón García A; Sampedro Nuño A
Arch Esp Urol; 2000; 53(1):29-36. PubMed ID: 10730422
[TBL] [Abstract][Full Text] [Related]
5. Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases.
Shaaban AA; Elbaz MA; Tribukait B
Urology; 1998 Mar; 51(3):469-76. PubMed ID: 9510355
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study.
Lopez-Beltran A; Croghan GA; Croghan I; Matilla A; Gaeta JF
Am J Clin Pathol; 1994 Jul; 102(1):109-14. PubMed ID: 8037155
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
[TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy analysis of invasive bladder cancer by flow cytometry.
Badalament RA; Smith JJ; Franklin GL; Drago JR
In Vivo; 1990; 4(4):269-72. PubMed ID: 2103372
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
Sasaki K; Hamano K; Kinjo M; Hara S
Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of flow cytometric deoxyribonucleic acid parameters and histological features for prognosis of bladder cancer patients.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1991 Dec; 146(6):1530-4. PubMed ID: 1942334
[TBL] [Abstract][Full Text] [Related]
13. DNA-Flow cytometric analysis of bladder TCC using paraffin-embedded tissues.
Wu L; Lochhead A; Yang J; Ow KT; Russell PJ
Urol Int; 1998 Aug; 60(4):208-15. PubMed ID: 9701732
[TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis of the DNA content of the urinary bladder cancers--study on the DNA heterogeneity in bladder cancers].
Toyota K; Nagamori S; Kashiwagi A; Nonomura K; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1353-9. PubMed ID: 7474619
[TBL] [Abstract][Full Text] [Related]
15. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
17. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy.
Lipponen PK; Eskelinen MJ; Nordling S
Eur J Cancer; 1991; 27(7):877-81. PubMed ID: 1834120
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma.
Pinto AE; Chaves P; Fidalgo P; Oliveira AG; Leitão CN; Soares J
Dis Colon Rectum; 1997 Apr; 40(4):411-9. PubMed ID: 9106689
[TBL] [Abstract][Full Text] [Related]
19. [Bladder transitional cell carcinoma rating, systematization of grading and value of DNA ploidy].
Hierro Martín I; Alvarez Pérez M; Blanes Berenguel A; Quiñonero Díaz A; Díaz Cano S; García González I; Matilla Vicente A
Actas Urol Esp; 1999 Jun; 23(6):489-96. PubMed ID: 10464957
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometry in cancer of the bladder].
Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
